LY6E and neoplasm: LY6D, LY6E, LY6H, and LY6K have increased mRNA expression in tumor tissues of ovarian, colorectal, gastric, breast, lung, bladder, brain, cervical, esophageal, head and neck, and pancreatic cancer compared to adjacent normal tissues.